ConductScience.org, home

Trial · NCT01347762

Participant flow12

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDNabilone Titrated 2 mg Daily (Phase 1)10
Overall StudySTARTEDPlacebo (Phase 1)8
Overall StudySTARTEDNabilone Titrated to 4 mg Daily (Phase 2)16
Overall StudySTARTEDPlacebo (Phase 2)18
Overall StudyCOMPLETEDNabilone Titrated 2 mg Daily (Phase 1)6
Overall StudyCOMPLETEDPlacebo (Phase 1)6
Overall StudyCOMPLETEDNabilone Titrated to 4 mg Daily (Phase 2)7
Overall StudyCOMPLETEDPlacebo (Phase 2)10
Overall StudyNOT COMPLETEDNabilone Titrated 2 mg Daily (Phase 1)4
Overall StudyNOT COMPLETEDPlacebo (Phase 1)2
Overall StudyNOT COMPLETEDNabilone Titrated to 4 mg Daily (Phase 2)9
Overall StudyNOT COMPLETEDPlacebo (Phase 2)8

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01347762/flow